FDA Inspection 1052732 — Qilu Pharmaceutical (Inner Mongolia) Co., Ltd.
The FDA completed an inspection of Qilu Pharmaceutical (Inner Mongolia) Co., Ltd. on Apr 12, 2018 in Hohhot. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 12, 2018
- Fiscal Year
- 2018
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Hohhot (China)